We understand that every patient is unique and customized therapy is often necessary. To address this need, we offer sophisticated cardiovascular risk insights from Berkeley HeartLab test results combined with a personalized approach to disease management.

We strive to help clinicians reduce risk through personalized therapy. Our passion lies in slowing
and ultimately preventing the progression of cardiovascular disease.

Personalized cardiovascular risk reduction goals for patients based on clinician's treatment plans, Berkeley HeartLab test results, current lifestyle, and health history.

Berkeley HeartLab announces new laboratory requisition forms.

KIF6 data from the CARE, WOSCOPS, PROSPER and PROVE-IT studies will be presented at the upcoming NLA meeting in Boston on June 13, 2009

New study expands the number of populations where KIF6 has been shown to predict increased risk of a coronary event

Berkeley HeartLab opens new 4myheart Centers for cardiovascular disease management